Asset
TINLAREBANT
Belite Bio Inc American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04005807 | phase1 | completed | 2019-07-19 | 2019-12-20 | Belite Bio, Inc | Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults |
FDA applications (0)
This company has no applications containing this asset.